Skip to main content
Publications
Dubath C, Gholam-Rezaee M, Sjaarda J, Levier A, Saigi-Morgui N, Delacretaz A, Glatard A, Panczak R, Correll CU, Solida A, Plessen KJ, von Gunten A, Kutalik Z, Conus P, Eap CB. Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort. Transl Psychiatry. 2021 Jun 26;11(1):360. doi: 10.1038/s41398-021-01482-9
Nagar SP, Rane PP, Fox KM, Meyers J, Davis K, Beaubrun A, Inomata H, Qian Y, Kajinami K. Treatment patterns, statin intolerance, and subsequent cardiovascular events among Japanese patients with high cardiovascular risk initiating statin therapy. Circ J. 2018 Mar 23;82(4):1008-16. doi: 10.1253/circj.CJ-17-0811
Sauchelli S, Jimenez-Murcia S, Sanchez I, Riesco N, Custal N, Fernandez-Garcia JC, Garrido-Sanchez L, Tinahones FJ, Steiger H, Israel M, Banos RM, Botella C, De la Torre R, Fernandez-Real JM, Ortega FJ, Fruhbeck G, Granero R, Tarrega S, Crujeiras AB, Rodriguez A, Estivill X, Beckmann JS, Casanueva FF, Menchon JM, Fernandez-Aranda F. Orexin and sleep quality in anorexia nervosa: clinical relevance and influence on treatment outcome. Psychoneuroendocrinology. 2016 Mar;65:102-8. doi: 10.1016/j.psyneuen.2015.12.014